Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance Report [Yahoo! Finance]
Catheter Precision, Inc. (VTAK)
Company Research
Source: Yahoo! Finance
of cardiac electrophysiology, including its VIVO™ and LockeT product(s), releases Q1 Financials, Operational Report for the quarter ending March 31, 2024. Operational highlights of the first quarter and early second quarter 2024 include the following: Submission of LockeT for CE Mark approval, which is expected in Q3 2024. First published data on initial LockeT clinical study of over 100 patients presented at Western Atrial Fibrillation Symposium . Data included: 100% immediate hemostasis. Allows for same day discharge. Effective at wound closure up to 27F which includes cardiac catheters and products such as left atrial appendage devices and leadless pacemakers. Reduction in the need for multiple closure devices. Attendance at the European Heart Rhythm Association (EHRA) conference Attendance at Monaco USA Arrhythmia Conference ( MUAC ) at which positive interim study data related to VIVO was presented on the accuracy of VIVO when used for ventricular ablation on in
Show less
Read more
Impact Snapshot
Event Time:
VTAK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTAK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTAK alerts
High impacting Catheter Precision, Inc. news events
Weekly update
A roundup of the hottest topics
VTAK
News
- Catheter Precision, Inc. (NYSE: VTAK) Announces Initial Orders from Ronald Reagan UCLA Medical Center and Rady Children's Hospital in San Diego for LockeT [Yahoo! Finance]Yahoo! Finance
- Catheter Precision, Inc. (NYSE: VTAK) Announces Initial Orders from Ronald Reagan UCLA Medical Center and Rady Children’s Hospital in San Diego for LockeTAccesswire
- Catheter Precision, Inc. (VTAK) Announces Receipt of New Purchase Order and Product Evaluation at New Hospital [Yahoo! Finance]Yahoo! Finance
- Catheter Precision, Inc. (VTAK) Announces Receipt of New Purchase Order and Product Evaluation at New HospitalAccesswire
- Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance ReportAccesswire
VTAK
Sec Filings
- 5/16/24 - Form DEFA14A
- 5/16/24 - Form ARS
- 5/16/24 - Form DEFA14A
- VTAK's page on the SEC website